Clinical Research Directory
Browse clinical research sites, groups, and studies.
Desloratadine in Patients With Ulcerative Colitis
Sponsor: Tanta University
Summary
The purpose of this study is to investigate safety and therapeutic efficacy of antihistamine (desloratadine) on inflammation and disease activity when administered as adjuvant therapies with the traditional therapy 5-aminosalisylic acid (mesalamine) in patients with mild to moderate ulcerative colitis.
Official title: Efficacy and Safety of Desloratadine as Adjuvant Therapy in Patients With Ulcerative Colitis
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
44
Start Date
2026-01-26
Completion Date
2027-03
Last Updated
2026-01-29
Healthy Volunteers
No
Interventions
Desloratadine
mesalamine 1000 mg three times daily plus desloratadine 5 mg once daily for 3 months.
mesalamine
mesalamine 1000 mg three times daily for 3 months
Locations (1)
Menofia university Hospitals
Shibīn al Kawm, Menofia, Egypt